About Neurotrack
Neurotrack is a digital health company on a mission to transform the diagnosis and management of Alzheimer's and other dementias. The company develops turnkey tools for providers that can be easily delivered at scale to facilitate early detection of cognitive impairment and ongoing monitoring of cognitive function. Neurotrack's patient-guided, clinically validated cognitive assessments work in the clinic or at home to fit any workflow. Neurotrack has published 27 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. For more information, visit neurotrack.com.
The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.
Company details
Funding
Total raised
$57.8M
Last stage
Series C
Investors
Founders
Stuart Zola
Neuroscientist and co-founder of Neurotrack. His research formed the scientific basis of Neurotrack's cognitive assessment technology, originally developed at Emory University.
Elizabeth Buffalo
Neuroscientist and co-founder of Neurotrack, partnered with Elli Kaplan in 2012 to found the company.
Elli Kaplan
Co-founder and CEO of Neurotrack. Career spans two decades in public and private sectors including the White House, State and Treasury Departments, UN Development Program, AIG Capital Partners, and Goldman Sachs. MBA from Harvard Business School.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.